EXABS-244-CT Should Patients with AML and Active Disease be Transplanted? von Gyurkocza, Boglarka

Volltext

Microbiota as Predictor of Mortality in Allogeneic Hematopoietic-Cell Transplantation von Peled, Jonathan U, Gomes, Antonio L.C, Devlin, Sean M, Littmann, Eric R, Taur, Ying, Sung, Anthony D, Weber, Daniela, Hashimoto, Daigo, Slingerland, Ann E, Slingerland, John B, Maloy, Molly, Clurman, Annelie G, Stein-Thoeringer, Christoph K, Markey, Kate A, Docampo, Melissa D, Burgos da Silva, Marina, Khan, Niloufer, Gessner, André, Messina, Julia A, Romero, Kristi, Lew, Meagan V, Bush, Amy, Bohannon, Lauren, Brereton, Daniel G, Fontana, Emily, Amoretti, Luigi A, Wright, Roberta J, Armijo, Gabriel K, Shono, Yusuke, Sanchez-Escamilla, Míriam, Castillo Flores, Nerea, Alarcon Tomas, Ana, Lin, Richard J, Yáñez San Segundo, Lucrecia, Shah, Gunjan L, Cho, Christina, Scordo, Michael, Politikos, Ioannis, Hayasaka, Kasumi, Hasegawa, Yuta, Gyurkocza, Boglarka, Ponce, Doris M, Barker, Juliet N, Perales, Miguel-Angel, Giralt, Sergio A, Jenq, Robert R, Teshima, Takanori, Chao, Nelson J, Holler, Ernst, Xavier, Joao B, Pamer, Eric G, van den Brink, Marcel R.M

Volltext

Comparison of minimal residual disease as outcome predictor for AML patients in first complete remission undergoing myeloablative or nonmyeloablative allogeneic hematopoietic cell... von Walter, R B, Gyurkocza, B, Storer, B E, Godwin, C D, Pagel, J M, Buckley, S A, Sorror, M L, Wood, B L, Storb, R, Appelbaum, F R, Sandmaier, B M

Volltext

Conditioning regimens for hematopoietic cell transplantation: one size does not fit all von Gyurkocza, Boglarka, Sandmaier, Brenda M.

Volltext

Allogeneic hematopoietic cell transplantation in patients with AML not achieving remission: potentially curative therapy von Gyurkocza, B, Lazarus, H M, Giralt, S

Volltext

Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation von Peled, Jonathan U, Devlin, Sean M, Staffas, Anna, Lumish, Melissa, Khanin, Raya, Littmann, Eric R, Ling, Lilan, Kosuri, Satyajit, Maloy, Molly, Slingerland, John B, Ahr, Katya F, Porosnicu Rodriguez, Kori A, Shono, Yusuke, Slingerland, Ann E, Docampo, Melissa D, Sung, Anthony D, Weber, Daniela, Alousi, Amin M, Gyurkocza, Boglarka, Ponce, Doris M, Barker, Juliet N, Perales, Miguel-Angel, Giralt, Sergio A, Taur, Ying, Pamer, Eric G, Jenq, Robert R, van den Brink, Marcel R M

Volltext

Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy von Zhang, Michael Y, Churpek, Jane E, Keel, Siobán B, Walsh, Tom, Lee, Ming K, Loeb, Keith R, Gulsuner, Suleyman, Pritchard, Colin C, Sanchez-Bonilla, Marilyn, Delrow, Jeffrey J, Basom, Ryan S, Forouhar, Melissa, Gyurkocza, Boglarka, Schwartz, Bradford S, Neistadt, Barbara, Marquez, Rafael, Mariani, Christopher J, Coats, Scott A, Hofmann, Inga, Lindsley, R Coleman, Williams, David A, Abkowitz, Janis L, Horwitz, Marshall S, King, Mary-Claire, Godley, Lucy A, Shimamura, Akiko

Volltext

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission von Walter, Roland B., Buckley, Sarah A., Pagel, John M., Wood, Brent L., Storer, Barry E., Sandmaier, Brenda M., Fang, Min, Gyurkocza, Boglarka, Delaney, Colleen, Radich, Jerald P., Estey, Elihu H., Appelbaum, Frederick R.

Volltext

Graft-Versus-Host Disease and Graft-Versus-Tumor Effects After Allogeneic Hematopoietic Cell Transplantation von Storb, Rainer, Gyurkocza, Boglarka, Storer, Barry E, Sorror, Mohamed L, Blume, Karl, Niederwieser, Dietger, Chauncey, Thomas R, Pulsipher, Michael A, Petersen, Finn B, Sahebi, Firoozeh, Agura, Edward D, Hari, Parameswaran, Bruno, Benedetto, McSweeney, Peter A, Maris, Michael B, Maziarz, Richard T, Langston, Amelia A, Bethge, Wolfgang, Vindeløv, Lars, Franke, Georg-Nikolaus, Laport, Ginna G, Yeager, Andrew M, Hübel, Kai, Deeg, H Joachim, Georges, George E, Flowers, Mary E D, Martin, Paul J, Mielcarek, Marco, Woolfrey, Ann E, Maloney, David G, Sandmaier, Brenda M

Volltext

Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS von Deeg, H. Joachim, Scott, Bart L., Fang, Min, Shulman, Howard M., Gyurkocza, Boglarka, Myerson, David, Pagel, John M., Platzbecker, Uwe, Ramakrishnan, Aravind, Radich, Jerald P., Sandmaier, Brenda M., Sorror, Mohamed, Stirewalt, Derek L., Wilson, Wendy A., Storb, Rainer, Appelbaum, Frederick R., Gooley, Ted

Volltext

Off-the-shelf EBV-specific T cell immunotherapy for rituximab-refractory EBV-associated lymphoma following transplantation von Prockop, Susan, Doubrovina, Ekaterina, Suser, Stephanie, Heller, Glenn, Barker, Juliet, Dahi, Parastoo, Perales, Miguel A, Papadopoulos, Esperanza, Sauter, Craig, Castro-Malaspina, Hugo, Boulad, Farid, Curran, Kevin J, Giralt, Sergio, Gyurkocza, Boglarka, Hsu, Katharine C, Jakubowski, Ann, Hanash, Alan M, Kernan, Nancy A, Kobos, Rachel, Koehne, Guenther, Landau, Heather, Ponce, Doris, Spitzer, Barbara, Young, James W, Behr, Gerald, Dunphy, Mark, Haque, Sofia, Teruya-Feldstein, Julie, Arcila, Maria, Moung, Christine, Hsu, Susan, Hasan, Aisha, O'Reilly, Richard J

Volltext

Emapalumab as salvage therapy for adults with malignancy-associated hemophagocytic lymphohistiocytosis von Johnson, William T, Epstein-Peterson, Zachary D, Ganesan, Nivetha, Pak, Timothy, Chang, Tiffany, Dao, Phuong, Moskowitz, Alison J, Stuver, Robert N, Ghione, Paola, Galasso, Natasha, Khan, Niloufer, Palomba, M Lia, Caron, Philip C, Kumar, Anita, Tamari, Roni, Lue, Jennifer K, Noy, Ariela, Falchi, Lorenzo, Intlekofer, Andrew M, Gyurkocza, Boglarka, Perales, Miguel-Angel, Scordo, Michael, Herskovits, A Zara, Salles, Gilles, Vardhana, Santosha A, Horwitz, Steven M

Volltext

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients With Acute Myeloid Leukemia von GYURKOCZA, Boglarka, STORB, Rainer, BRUNO, Benedetto, PETERSEN, Finn B, MARIS, Michael B, AGURA, Edward, YEAGER, Andrew, BETHGE, Wolfgang, SAHEBI, Firoozeh, APPELBAUM, Frederick R, MALONEY, David G, SANDMAIER, Brenda M, STORER, Barry E, CHAUNCEY, Thomas R, LANGE, Thoralf, SHIZURU, Judith A, LANGSTON, Amelia A, PULSIPHER, Michael A, BREDESON, Christopher N, MAZIARZ, Richard T

Volltext

Allogeneic hematopoietic cell transplantation with non-myeloablative conditioning for patients with hematologic malignancies: Improved outcomes over two decades von Cooper, Jason P, Storer, Barry E, Granot, Noa, Gyurkocza, Boglark, Sorror, Mohamed L, Chauncey, Thomas R, Shizuru, Judith, Franke, Georg-Nikolaus, Maris, Michael B, Boyer, Michael, Bruno, Benedetto, Sahebi, Firoozeh, Langston, Amelia A, Hari, Parameswaran, Agura, Edward D, Lykke Petersen, Søren, Maziarz, Richard T, Bethge, Wolfgang, Asch, Julie, Gutman, Jonathan A, Olesen, Gitte, Yeager, Andrew M, Hübel, Kai, Hogan, William J, Maloney, David G, Mielcarek, Marco, Martin, Paul J, Flowers, Mary E D, Georges, George E, Woolfrey, Ann E, Deeg, Joachim H, Scott, Bart L, McDonald, George B, Storb, Rainer, Sandmaier, Brenda M

Volltext

Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies von Stuver, Robert, Shah, Gunjan L., Korde, Neha S., Roeker, Lindsey E., Mato, Anthony R., Batlevi, Connie L., Chung, David J., Doddi, Sital, Falchi, Lorenzo, Gyurkocza, Boglarka, Hamilton, Audrey, Lin, Ya-Hui, Jakubowski, Ann A., Joffe, Erel, Landau, Heather L., Lin, Richard J., Mailankody, Sham, Palomba, M. Lia, Park, Jae H., Perales, Miguel-Angel, Ponce, Doris M., Ramanathan, Lakshmi V., Salles, Gilles A., Scordo, Michael, Seo, Susan K., Shah, Urvi A., Stein, Eytan M., Straus, David, Usmani, Saad Z., Young, James W., Zelenetz, Andrew D., Noy, Ariela, Vardhana, Santosha A.

Volltext

Isatuximab for Delayed Red Cell Engraftment after Allogeneic Hematopoietic Cell Transplantation von Nauffal, Mary, Eng, Stephen, Lin, Andrew, Chan, Alexander, Mazzerella, Kathryn, Giralt, Sergio, Perales, Miguel-Angel, Gyurkocza, Boglarka

Volltext

Analysis of 3,843 Unrelated Donors (URD) for 455 Allograft Candidates Reveals Low URD Availability with Marked Racial/ Ethnic Disparities: Major Implications for Transplant Center... von Fingrut, Warren B, Davis, Eric, Archer, Anne, Brown, Samantha, Devlin, Sean M., Nhaissi, Melissa, Rapoport, Candice, Chinapen, Stephanie, Kelly, Amanda, Wells, Deborah, Scaradavou, Andromachi, Gyurkocza, Boglarka, Papadopoulos, Esperanza B., Politikos, Ioannis, Shaffer, Brian C., Barker, Juliet N

Volltext

Use of a Tissue-Targeting Recombinant Human Interleukin-22 Fusion Molecule (F-652) for the Treatment of Advanced Refractory Lower GI Acute Gvhd von Satta, Toshihisa, Papadopoulos, Esperanza B., Gyurkocza, Boglarka, Susman, Pamela, Singh, Amandeep, Calafiore, Marco, Giralt, Sergio A., Perales, Miguel-Angel, Chen, Jianmin, Li, Simon, Peled, Jonathan U., van den Brink, Marcel R.M., Hanash, Alan M., Ponce, Doris M.

Volltext

High Progression-Free Survival with Low Relapse Rates after Double-Unit Cord Blood Transplantation in Patients with High-Risk AML von Politikos, Ioannis, Fingrut, Warren B, Brown, Samantha, Chinapen, Stephanie, Quach, Sean, Dahi, Parastoo B., Gyurkocza, Boglarka, Jakubowski, Ann A., Papadopoulos, Esperanza B., Ponce, Doris M., Tamari, Roni, Perales, Miguel-Angel, Scaradavou, Andromachi, Barker, Juliet N

Volltext

Topical Ruxolitinib for Chronic Cutaneous GvHD: Promising Results of a Phase 2 Clinical Trial von Markova, Alina, Papadopoulos, Esperanza B., Dusza, Stephen, Ostojić, Jelena, Ai, Rizi, Maier, Tara, Lacouture, Mario, Tamari, Roni, Gyurkocza, Boglarka, Shaffer, Brian C., Scordo, Michael, Perales, Miguel-Angel, Harris, Andrew, Ponce, Doris M.

Volltext